Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone vs Aripiprazole in Inpatient Schizophrenia
NCT00634348Phase 4Completed
- Sponsor
- Viatris
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ziprasidone in schizophrenia and schizoaffective disorder (2 arms), sponsored by Viatris. Primary endpoints: Clinical Global Impressions-Severity at 28 days and Brief Psychiatric Rating Scale derived at 28 days. Started Apr 2004; status: completed.
02
Drugs
ziprasidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00634348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634348.